** Shares of Regal Asian Investments RG8.AX fall as much as 3.8% to A$1.915, their lowest level since Dec 8, 2023
** Stock posts biggest intraday decline since Feb 20
** Investment manager devalues stake in biotech Opthea OPT.AX to A$0.20/shr vs OPT's last close of A$0.60 before trading was suspended
** OPT on Monday warned of insolvency after its late-stage trial for its wet age-related macular degeneration injection failed
** RG8 stock last down 2%, bringing YTD losses to 8.9%.
(Reporting by Aaditya Govind Rao in Bengaluru)
((Aaditya.govindrao@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。